Literature DB >> 11265893

Radiofrequency thermal ablation of a splenic metastasis.

B J Wood1, S Bates.   

Abstract

Effective local ablation of large tumors with radiofrequency has been made possible by recent advancements. Tumor ablation with radiofrequency has been described mainly in the liver, but also recently in the kidney, adrenal gland, lung, and breast. A rapidly growing splenic metastasis from renal cell carcinoma was effectively treated percutaneously, with US guidance. Focal splenic disease may not be a common indication for ablation; however, further work is necessary to evaluate the safety and efficacy of this procedure in this setting.

Entities:  

Mesh：

Year:  2001        PMID： 11265893      PMCID： PMC2375914          DOI： 10.1016/s1051-0443(07)61835-1

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


  10 in total

1.  Percutaneous imaging-guided biopsy of the spleen.

Authors:  M E O'Malley; B J Wood; G W Boland; P R Mueller
Journal:  AJR Am J Roentgenol       Date:  1999-03       Impact factor: 3.959

2.  Percutaneous lieno-portal venography: technique and complications.

Authors:  I BERGSTRAND; C A EKMAN
Journal:  Acta radiol       Date:  1957-04       Impact factor: 1.990

3.  How to use cytodiagnostic spleen puncture.

Authors:  N Söderström
Journal:  Acta Med Scand       Date:  1976

4.  Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness.

Authors:  M T Keogan; K S Freed; E K Paulson; R C Nelson; L G Dodd
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

5.  Control of splenic bleeding by using high intensity ultrasound.

Authors:  S Vaezy; R Martin; G Keilman; P Kaczkowski; E Chi; E Yazaji; M Caps; S Poliachik; S Carter; S Sharar; C Cornejo; L Crum
Journal:  J Trauma       Date:  1999-09

6.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.

Authors:  S A Curley; F Izzo; P Delrio; L M Ellis; J Granchi; P Vallone; F Fiore; S Pignata; B Daniele; F Cremona
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma.

Authors:  R Bellantone; A Ferrante; M Boscherini; C P Lombardi; P Crucitti; F Crucitti; G Favia; D Borrelli; L Boffi; L Capussotti; G Carbone; M Casaccia; A Cavallaro; A Del Gaudio; G Dettori; V Di Giovanni; A Mazziotti; D Marrano; E Masenti; P Miccoli; F Mosca; A Mussa; R Petronio; G Piat; L Marazano
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

8.  Interventional radiology in the spleen.

Authors:  S F Quinn; E vanSonnenberg; G Casola; G R Wittich; C C Neff
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

Review 9.  New applications of ultrasonography: interventional ultrasound.

Authors:  L Solbiati
Journal:  Eur J Radiol       Date:  1998-05       Impact factor: 3.528

10.  Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.

Authors:  B Nordlinger; M Guiguet; J C Vaillant; P Balladur; K Boudjema; P Bachellier; D Jaeck
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860
  10 in total
  10 in total

Review 1.  Percutaneous ablation in the kidney.

Authors:  Aradhana M Venkatesan; Bradford J Wood; Debra A Gervais
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

2.  Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option.

Authors:  Guilherme Lopes P Martins; Joao Paulo G Bernardes; Marcello S Rovella; Raphael G Andrade; Publio Cesar C Viana; Paulo Herman; Giovanni Guido Cerri; Marcos Roberto Menezes
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 3.  Percutaneous tumor ablation with radiofrequency.

Authors:  Bradford J Wood; Jeffrey R Ramkaransingh; Tito Fojo; McClellan M Walther; Stephen K Libutti
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism.

Authors:  Quan-Da Liu; Kuan-Sheng Ma; Zhen-Ping He; Jun Ding; Xue-Quan Huang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

6.  Magnetic Resonance Mediated Radiofrequency Ablation.

Authors:  Yik-Kiong Hue; Alexander R Guimaraes; Ouri Cohen; Erez Nevo; Abraham Roth; Jerome L Ackerman
Journal:  IEEE Trans Med Imaging       Date:  2017-09-18       Impact factor: 10.048

7.  Hepatectomy combined with microwave ablation of the spleen for treatment of hepatocellular carcinoma complicated with splenomegaly: A retrospective study.

Authors:  Jian-Bo Han; Feng-Wei Kong; Hai Ding; Yu-Feng Zhang; Jun-Mao Liu; Qiang Wei; Liang Hu; Liang Zhao; Chuan-Jun Xu; Yong-Xiang Yi
Journal:  Mol Clin Oncol       Date:  2016-12-14

Review 8.  Surgical management of metastases to the adrenal gland: open, laparoscopic, and ablative approaches.

Authors:  Jayant Uberoi; Ravi Munver
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

Review 9.  Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland.

Authors:  Ravi Munver; Joseph J Del Pizzo; R Ernest Sosa
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

10.  Analysis of feasibility, safety and effectiveness of ultrasound-guided percutaneous microwave ablation of splenic neoplasm.

Authors:  Na Luo; Yan Wang; Zhe Geng; Xiantao Qin
Journal:  Oncol Lett       Date:  2018-01-23       Impact factor: 2.967
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.